Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Alaska Air Group Inc ALK

Alaska Air Group, Inc. is engaged in operating airlines. The Company operates two airlines, Alaska, and Horizon. It also includes McGee Air Services, an aviation services provider. It operates through three segments: Mainline, Regional and Horizon. The Mainline segment includes scheduled air transportation on Alaska's Boeing 737 (B737) aircraft for passengers and cargo throughout the United States, and in parts of Mexico, Costa Rica, Belize, the Bahamas, and Guatemala. The Regional segment includes Horizon's and other third-party carriers scheduled air transportation on Embraer E175 (E175) aircraft for passengers across a shorter distance network within the United States, Canada, and Mexico under capacity purchase agreements (CPA). The Horizon segment includes the capacity sold to Alaska under a CPA. With its regional partners, it flies to more than 120 destinations throughout North America. It provides its guests with global access to more than 900 destinations in 170 territories.


NYSE:ALK - Post by User

Post by Jannineon Feb 04, 2022 10:28am
58 Views
Post# 34397320

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS VideoFSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid-MS is an industry-first and we want to share the visual evidence of functional recovery of pre-clinical subjects in this video!
<< Previous
Bullboard Posts
Next >>